Gateway™ LR Clonase™ Enzyme mix
Product Image
Invitrogen™

Gateway™ LR Clonase™ Enzyme mix

Gateway® LR Clonase® II酵素ミックスにはInt(Integrase)、IHF(Integration Host Factor詳細を見る
製品番号(カタログ番号)数量
1179101920反応
11791043100反応
製品番号(カタログ番号) 11791019
価格(JPY)
77,800
Each
お問い合わせください ›
数量:
20反応
Gateway® LR Clonase® II酵素ミックスにはInt(Integrase)、IHF(Integration Host Factor)およびXis(Excisionase)タンパク質を含みます。エントリークローン(目的遺伝子の両末端にattL配列が付加されている)とデスティネーションベクター(attR配列を含む)の間でのin vitroの組換え反応を触媒し、発現クローン作製に使用されます。お客様のアプリケーション、ご希望のフォーマットに合わせ、さまざまなフォーマットのLR Clonase酵素ミックスをご用意しております。LR Clonase II Plus酵素ミックスは、最高の組換え効率を提供する最新バージョンで(表1)、単一フラグメントと複数フラグメントの両方のクローニングに特異的に最適化されています(表1)。LR Clonase II Plus酵素ミックスは、酵素と反応バッファーを最適化した一つのミックスで提供し、単一フラグメントと複数フラグメントの両方のクローニングに適した酵素の安定性と使いやすさを少ないピペット操作で実現します。当社のLRクロナーゼ II酵素ミックスは、単一のミックスフォーマットでもご利用いただけますが、オリジナルのLRクロナーゼ®酵素は、個別のチューブ入りの酵素とバッファーです
研究用にのみ使用できます。診断用には使用いただけません。
仕様
適合バッファー反応バッファー
製品タイプLRクロナーゼ酵素ミックス
数量20反応
出荷条件ドライアイス
酵素LRクロナーゼ
製品ラインClonase, Gateway
Unit SizeEach
組成および保存条件
すべてのGateway™ LRクロナーゼ™酵素キットには、プロテイナーゼK溶液(2 µg/µl)とポジティブコントロールベクターが含まれます。LRクロナーゼ™酵素は-80℃で保存し、LRクロナーゼ™IIまたはII Plus酵素混合物は-20℃で保存します。適切に保存した場合、6カ月間安定しています。

よくあるご質問(FAQ)

I performed an LR reaction and got high background after transformation. Can you please offer some troubleshooting tips?

– Check whether the reaction was transformed into an E.coli strain containing the F' episome and the ccdA gene – use an E.coli strain that does not contain the F&339; episome, e.g. OmniMAX 2-T1R, TOP10.
– Deletion (full or partial) of the ccdB gene – propagate in media with 50-100 mg/mL ampicillin and 15-30 µg/mL chloramphenicol.
– Contamination from another resistant strain.
– Check whether proper amount of DNA was used in the reaction.

I performed an LR reaction and got two distinct types of colonies (large and small) after transformation. What could be the possible reasons?

– Plasmid was lost during culture due to large size or toxicity – try incubating at 30 degrees C; use Stbl2 E.coli to stabilize the plasmid.
– Deletions (full or partial) or point mutations in the ccdB gene – obtain a new Destination vector.
– Small colonies may be unreacted entry clone that co-transforms with the Expression clone – reduce the amount of Entry clone to 50 ng per 10 µL reaction; reduce the volume of sample used for transformation to 1 µL; for a Destination vector with ampicillin selection marker, increase the ampicillin concentration to 300 µg/mL.

I performed an LR reaction and got no colonies after transformation, and the recombination positive control was not successful. Can you please offer some suggestions?

– Check the competent cells with pUC19 transformation.
– Increase the amount plated.

I performed an LR reaction and got few or no colonies after transformation, whereas the transformation control gave colonies. Can you please offer some suggestions?

– Increase the incubation time up to 18 hours.
– Make sure to treat reactions with proteinase K before transformation.
– Check whether the correct antibiotic was used for selection.
– Check whether the att site sequences are correct.
– Check whether the correct Clonase enzyme was used and whether it was functional.
– Check whether the recommended amount of DNA was used in the reaction.
– Perform the positive control recombination with pENTR-Gus plasmid.
– If the Entry clone or Destination vector is too large (>10 kb), incubate the LR reaction overnight, linearize the Destination vector or the Entry clone or relax the Destination vector with topoisomerase I.

Can I create a single Entry vector for use with DEST vectors that have N-terminal tags and C-terminal tags?

No, since a stop codon would be necessary for an N-terminal tagged destination vector, whereas the presence of a stop codon would block expression of the C-terminal tag.

引用および参考文献 (7)

引用および参考文献
Abstract
A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae.
Authors:Alberti S, Gitler AD, Lindquist S,
Journal:Yeast
PubMed ID:17583893
'In the post-genomic era, academic and biotechnological research is increasingly shifting its attention from single proteins to the analysis of complex protein networks. This change in experimental design requires the use of simple and experimentally tractable organisms, such as the unicellular eukaryote Saccharomyces cerevisiae, and a range of new high-throughput ... More
Development of R4 gateway binary vectors (R4pGWB) enabling high-throughput promoter swapping for plant research.
Authors:Nakagawa T, Nakamura S, Tanaka K, Kawamukai M, Suzuki T, Nakamura K, Kimura T, Ishiguro S,
Journal:Biosci Biotechnol Biochem
PubMed ID:18256458
We developed a new series of Gateway binary vectors, R4pGWBs, that are plant transformation vectors designed for one-step construction of chimeric genes between any promoter and any cDNA. The structure of R4pGWBs is almost the same as the promoterless type of improved pGWBs (ImpGWBs), except that the attR1 site is ... More
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.
Authors:Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS,
Journal:Genes Dev
PubMed ID:11959843
RNA interference (RNAi) was first recognized in Caenorhabditis elegans as a biological response to exogenous double-stranded RNA (dsRNA), which induces sequence-specific gene silencing. RNAi represents a conserved regulatory motif, which is present in a wide range of eukaryotic organisms. Recently, we and others have shown that endogenously encoded triggers of ... More
Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme.
Authors:Wang Y, Bruenn JA, Queener SF, Cody V,
Journal:Antimicrob Agents Chemother
PubMed ID:11502523
While assays of many antifolate inhibitors for dihydrofolate reductase (DHFR) have been performed using rat DHFR as a target, neither the sequence nor the structure of rat DHFR is known. Here, we report the isolation of the rat DHFR gene through screening of a rat liver cDNA library. The rat ... More
High throughput immuno-screening of cDNA expression libraries produced by in vitro recombination; exploring the Plasmodium falciparum proteome.
Authors:Kordai Sowa MP, Sharling L, Humphreys G, Cavanagh DR, Gregory WF, Fenn K, Creasey AM, Arnot DE,
Journal:Mol Biochem Parasitol
PubMed ID:14698438
Improved Plasmodium falciparum cDNA expression libraries were constructed by combining mRNA oligo-capping with in vitro recombination and directional cloning of cDNA inserts into a plasmid vector that expresses sequences as thioredoxin fusion proteins. A novel procedure has also been developed for the rapid identification of seropositive clones on high-density filters, ... More